Neurology and CNS Clinical Development

Driving successful outcomes for CNS and Neurology trials is challenging

Second, only to Oncology, CNS and Neurology clinical trials are incredibly complex and complicated to navigate. CNS trials are plagued with high failure rates at or before phase III, and therefore require careful risk mitigation throughout trial design and execution with close regulatory agency collaboration.

That is why Veristat has built a team of scientific-minded experts who have supported more than 150 clinical trials, including drug, biologic, and diagnostic trials. More than 40% of these treatments are for rare neurological diseases or disorders. 

Driving CNS and Neurology Treatments to Approval

Our diverse trial experience, coupled with our knowledgeable and experienced teams, allows us to confidently handle the most complex trials and patient populations with the attention and focus needed to navigate the neurological disease landscape.

At Veristat, our experienced teams are poised to plan and implement these efforts quickly providing:     


> 150

clinical trials supported for CNS/Neurology Disorders



clinical trials are rare disorders

Veristat_icon_gene therapy

> 25%

clinical trials are genetic neurological disorders

Explore Our Recent Neurology Experience

>150 CNS/Neurology clinical trials for drugs, biologics, cell therapies, gene therapies, and diagnostics

Neurology Indications
Pain & Inflammation
Alzheimer's Disease
Friedreich's Ataxia
Parkinson's Disease
Amyotrophic lateral sclerosis (ALS) 
Genetic Abnormalities
Pompe Disease
Attention Deficit Disorder (ADD)
Hearing Loss
Post-Operative Pain
Attention Deficit/Hyperactivity Disorder (ADHD) 
Sanfilippo Syndrome
Autism Spectrum Disorder
Limb Girdle Muscular Dystrophy Type 2i (LGMD2i)
Canavan Disease 
Lumbar Radiculopathy 
Sjogren-Larsson Syndrome (SLS)
Cerebral Adrenoleukodystrophy (CALD)
Maroteaux-Lamy Syndrome 
Sleep Apnea/ Sleep Dysfunction
Diabetic Neuropathy Pain 
Multiple Sclerosis (MS) 
Spasticity Due to Spinal Cord Injury 
Dravet Syndrome 
Nocturnal Foot and/or leg cramps
Spinocerebellar Ataxia (SCA)
Duchenne Muscular Dystrophy 
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) 
Tardive Dyskinesia


Learn More with These Resources

Webinar Presentation
Webinar: Virtual Trial Planning Lessons Learned

Get the webinar presentation to see lessons learned and recommendations for designing protocols that enable flexibility in your virtual trials' ...

Case Study
Overcoming an NDA Refusal To File

Learn how the right biostatistical experts performed a quality review of the clinical data for an NDA that received a Refusal-to-File from the FDA.

Case Study
Stem Cell Therapy for Stroke Patients

A client engaged the Veristat team in a Phase II study of intracerebral stem cell injection in patients following an ischemic stroke. The goal was to look at limb ...

Request A Proposal